At-Home Ketamine and Infusion Clinics: Comparing Important Differences

At-home ketamine and an infusion-clinic visit involve different routes, products, and levels of onsite support. Choosing a setting requires a medical assessment. Cost, privacy, and convenience may affect your preferences, but they cannot establish that two options have comparable safety or effectiveness.

Compounded ketamine is not FDA-approved. FDA has not reviewed compounded medications for safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric disorders. Compounded ketamine nasal spray is different from Spravato, the FDA-approved esketamine product used in certified healthcare settings.

What changes with the route and product?

Intravenous treatment delivers medication through an IV. Compounded nasal, oral, or sublingual products use other routes. The amount administered, absorption, and treatment protocols differ, so a dose or study result cannot simply be transferred between them.

Ketamine injection’s approval for anesthesia does not make an infusion for a psychiatric condition FDA-approved. Spravato is a separate esketamine medication with specific approved indications and required use in certified healthcare settings. Ask which exact product a clinic offers rather than assuming “ketamine treatment” names one standard service.

What changes with supervision?

An in-person clinic may provide observation and access to staff during administration; ask exactly what its team monitors and how it handles an emergency. Clinic protocols and capabilities can vary. The presence of a building or an IV does not guarantee that every possible risk is addressed.

With at-home use, a healthcare professional is not onsite to monitor alertness, breathing, or blood pressure, or to respond immediately. Scheduled virtual appointments do not reproduce that capability. Ask whether your health history or medications make onsite evaluation or monitoring particularly important.

Does one option work as well as the other?

Do not assume equivalence. Research using a particular infusion protocol or approved esketamine does not establish what a compounded at-home nasal spray will do. Your clinician should describe the evidence relevant to your diagnosis and product, the uncertainty, and the alternatives. Improvement is not guaranteed. For a concrete example of route-specific evidence, read about the limits of an at-home sublingual ketamine study.

Compare the entire plan and cost

• Include medication, administration, monitoring, and follow-up in written quotes.
• Ask about transportation and restrictions on driving or work.
• Confirm how side effects are reviewed between visits.
• Ask how benefit will be measured and when the plan will be reassessed.
• Review recurring-payment, cancellation, and refund terms.

Risks remain in either setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems are additional concerns. A prescription does not remove these risks. Discuss medication interactions and an emergency plan.

Use medication only as prescribed. A treatment that fits a budget or schedule may still be medically inappropriate. If you need urgent or emergency care, do not rely on a routine telehealth appointment.

Discuss your questions with a clinician

Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. If treatment is prescribed, an independent, appropriately licensed compounding pharmacy dispenses the medication. A consultation does not guarantee a prescription; applicable prescribing and compounding requirements must be met.

Book a Free Virtual Appointment or Follow-Up to review your questions, alternatives, and next steps. This article provides general education and does not replace individualized medical advice.

Further reading: FDA: compounded-drug risks; FDA: Spravato prescribing information.